Rheumatology International
短名 | Rheumatol Int |
Journal Impact | 3.39 |
国际分区 | RHEUMATOLOGY(Q2) |
期刊索引 | SCI Q2中科院 3 区 |
ISSN | 0172-8172, 1437-160X |
h-index | 89 |
国内分区 | 医学(3区)医学风湿病学(4区) |
RHEUMATOLOGY INTERNATIONAL 是一份反映世界范围内各种风湿性疾病研究、诊断和治疗进展的独立期刊。它旨在为风湿病学领域的研究人员和临床医生提供服务。风湿病学国际将涵盖临床研究以及风湿病管理的所有现代趋势。将特别强调与风湿病相关的公共卫生问题,将风湿病研究应用于临床实践,风湿病流行病学,风湿病诊断测试,风湿病患者报告结果(PROS)和风湿病教育证据。对这些主题的贡献将以原始出版物、简短的交流、社论和评论的形式出现。欢迎“致编辑的信”作为讨论的补充。不鼓励提交基础科学研究,包括体外或动物研究,因为我们只会从流行病学或临床角度审查对人类的研究。没有对文献(基于案例的评论)进行适当审查的病例报告将不会发表。将尽一切努力确保出版速度,同时保持高标准的内容和生产。提交出版的手稿必须包含声明,说明所有人体研究都已通过相应的伦理委员会审查,因此已按照符合 1964 年赫尔辛基宣言的适当版本中规定的道德标准。还应在正文中明确说明所有人员在纳入研究之前均已签署知情同意书。应省略可能披露研究对象身份的细节。
期刊主页投稿网址涉及主题 | 医学内科学生物心理学病理精神科放射科免疫学痹症科外科遗传学疾病化学类风湿性关节炎生物化学内分泌学关节炎胃肠病学数学物理疗法皮肤病科 |
出版信息 | 出版商: Springer Science and Business Media Deutschland GmbH,出版周期: Tri-annual,期刊类型: journal |
基本数据 | 创刊年份: 1981,原创研究文献占比: 67.69%,自引率:6.20%, Gold OA占比: 30.03% |
平均审稿周期 | 网友分享经验:平均16.月 |
平均录用比例 | 网友分享经验:约75% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Diabetes in axial spondyloarthritis: a systematic review and meta-analysis of observational studies
2024-9-12
Evaluation of tocilizumab-induced hypofibrinogenemia in rheumatology practice: a retrospective, real-life, single-center experience
2024-9-12
Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China
2024-9-12
Distinct clinical outcomes linked to peripheral arthritis and dactylitis in axial spondyloarthritis: findings from a retrospective Irish cohort
2024-9-10
SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature review
2024-9-9
Artificial intelligence-based quantification of pulmonary HRCT (AIqpHRCT) for the evaluation of interstitial lung disease in patients with inflammatory rheumatic diseases
2024-9-9
Anti-synthetase and myelodysplastic syndromes with deep morphea: an example of shared immunopathogenesis? A case-based review
2024-9-9
The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies
2024-9-8
Digital ischemia: a rare immune-related adverse event of immune checkpoint inhibitors—case report and review of the literature
2024-9-4
Posture, balance and gait in axial spondyloarthritis: a case-control study
2024-9-4
Correction: Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review
2024-9-2
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping review
2024-8-30
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
2024-8-29
Postpartum onset anti-MDA5 antibody-positive clinically amyopathic dermatomyositis; case-based review of perinatal onset anti-MDA5 antibody-positive dermatomyositis
2024-8-28
What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping review
2024-8-27
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports
2024-8-27
Global burden of musculoskeletal disorders in children and adolescents from 1990 to 2021: a joint point regression and decomposition analysis
2024-8-27
High-intensity resistance training improves quality of life, muscle endurance and strength in patients with myositis: a randomised controlled trial
2024-8-27
Heart involvement in patients with systemic sclerosis—what have we learned about it in the last 5 years
2024-8-27
Profile of juvenile systemic lupus erythematosus patients with a special reference to monogenic lupus and lupus nephritis: a cross-sectional study
2024-8-24
Is vitamin D associated with disease activity in patients with axial or peripheral spondyloarthritis? A real-life study
2024-8-24
Tuberculosis is the predominant infection in systemic sclerosis: thirty-year retrospective study of serious infections from a single centre
2024-8-24
Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study
2024-8-24
Association of serum and synovial adipokines (chemerin and resistin) with inflammatory markers and ultrasonographic evaluation scores in patients with knee joint osteoarthritis- a pilot study
2024-8-24
CA 15 − 3 in screening for systemic autoimmune rheumatic disease associated interstitial lung disease: a single center cross-sectional study
2024-8-24
Correction: Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study
2024-8-24
The influence of autoantibody profile, disease manifestations and demographic features on survival in systemic lupus erythematosus: a comparative study
2024-8-24
Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)
2024-8-24
Certolizumab-induced sarcoidosis in a patient with psoriatic arthritis – a case report and review of literature
2024-8-24
Adhesion molecules and atherosclerosis in ankylosing spondylitis: implications for cardiovascular risk
2024-8-24
Bilateral juvenile temporal arteritis: a case-based review
2024-8-24
Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patients
2024-8-21
Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study
2024-8-21
Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study
2024-8-21
Current investigation of the high prevalence of sexual dysfunction in female patients with systemic lupus erythematosus: a cross-sectional study
2024-8-17
Sexual dysfunction among female patients with rheumatic diseases
2024-8-17
Targeting complement dysregulation: eculizumab in scleroderma renal crisis management—a case-based review
2024-8-15
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
2024-8-13
The relationship between MRI-detected hip abnormalities and hip pain in hip osteoarthritis: a systematic review
2024-8-13
Distinct pulmonary patterns in ANCA-associated vasculitides: insights from a retrospective single center cohort study
2024-8-13
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network
2024-8-13
Central nervous system manifestations in rheumatic diseases
2024-8-13
Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study
2024-8-10
Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials
2024-8-8
The need for primary care providers in the clinical management of hypermobility spectrum disorders and ehlers-danlos syndrome: a call to action
2024-8-7
Complex rehabilitation of patients with rheumatoid arthritis
2024-8-3
Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional survey
2024-7-31
Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study
2024-7-29
Chronobiological variables predict non-response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia: a cross-sectional study
2024-7-29
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial
2024-7-24
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远